Joseph P. Casazza

Best Publications

• HIV preferentially infects HIV-specific CD4 + T cells

  Daniel C. Douek;Jason M. Brenchley;Michael R. Betts;David R. Ambrozak

  1720
  Citations

• Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

  Jason M. Brenchley;Nitin J. Karandikar;Michael R. Betts;David R. Ambrozak

  1271
  Citations

• PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

  Constantinos Petrovas;Joseph P. Casazza;Jason M. Brenchley;David A. Price

  1130
  Citations

• Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

  Robert A. Seder;Lee Jah Chang;Mary E. Enama;Kathryn L. Zephir

  920
  Citations

• Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

  Michael R. Betts;David R. Ambrozak;Daniel C. Douek;Sebastian Bonhoeffer

  887
  Citations

• T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis

  Jason M. Brenchley;Brenna J. Hill;David R. Ambrozak;David A. Price

  506
  Citations

• Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

  Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure

  503
  Citations

• Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

  Joseph P. Casazza;Michael R. Betts;David A. Price;Melissa L. Precopio

  419
  Citations

• Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.

  Natalie E. R. Beveridge;David A. Price;David A. Price;Joseph P. Casazza;Ansar A. Pathan

  340
  Citations

• Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

  Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  335
  Citations

• Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

  Martin R Gaudinski;Katherine V Houser;Kaitlyn M Morabito;Zonghui Hu

  316
  Citations

• Evidence for increased T cell turnover and decreased thymic output in HIV infection.

  Daniel C. Douek;Michael R. Betts;Brenna J. Hill;Susan J. Little

  299
  Citations

• A Novel Approach to the Analysis of Specificity, Clonality, and Frequency of HIV-Specific T Cell Responses Reveals a Potential Mechanism for Control of Viral Escape

  Daniel C. Douek;Daniel C. Douek;Michael R. Betts;Jason M. Brenchley;Brenna J. Hill

  296
  Citations

• Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection

  Christof Geldmacher;Njabulo Ngwenyama;Alexandra Schuetz;Constantinos Petrovas

  292
  Citations

• Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy

  Joseph P. Casazza;Michael R. Betts;Louis J. Picker;Richard A. Koup

  240
  Citations

• Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

  Takuya Yamamoto;David A. Price;David A. Price;Joseph P. Casazza;Guido Ferrari

  233
  Citations

• Early Depletion of Mycobacterium tuberculosis-Specific T Helper 1 Cell Responses after HIV-1 Infection

  Christof Geldmacher;Alexandra Schuetz;Njabulo Ngwenyama;Joseph P. Casazza

  230
  Citations

• Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

  Unknown

  204
  Citations

• Putative Immunodominant Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype

  Michael R. Betts;Joseph P. Casazza;Brent A. Patterson;Shar Waldrop

  191
  Citations

• Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.

  Constantinos Petrovas;Sara Ferrando-Martinez;Michael Y. Gerner;Joseph P. Casazza

  176
  Citations